Wednesday, 7 July 2010

MS Trust update on availability Sativex

From the MS Trust website:
Following some calls to our information team the MS Trust would like to clarify the prescribing situation for people who would potentially benefit from Sativex.
The cannabis-based mouth spray recently received its UK licence for treatment of MS spasticity in people who have shown inadequate response to other drug treatments or otherwise found their side effects unbearable.  Read more here.